NCT04884204View on ClinicalTrials.gov

Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms of Chronic GVHD in Outpatient Care in Patients Post HSCT

NACompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions

GVHD, ChronicHematological Malignancy

Interventions

BEHAVIORAL

Lee Symptom Scala

Symptom identification and management with Lee Symptom Scale in follow up care

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Novo Nordisk A/S

INDUSTRY

lead

Rigshospitalet, Denmark

OTHER

NCT04884204 - Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms of Chronic GVHD in Outpatient Care in Patients Post HSCT | Biotech Hunter | Biotech Hunter